CONTACT US

Side Effects/Safety:
za.chcdrugsafety@sanofi.com
Medical Queries:
za.chcenquiries@sanofi.com
Product Quality Complaints:
chc-zaqacomplaints@sanofi.com

PRODUCT AND SANOFI DETAILS

S1 BUSCOPAN® 10 mg tablets. Each tablet contains hyoscine butylbromide 10 mg. Ref. No. E 501 (Act 101/1965)
S1 BUSCOPAN® 0,1 % syrup.Each 5 ml of syrup contains 5 mg of hyoscine butylbromide. Reg. No. Z/11.2/93

For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.
Applicant: Opella Healthcare South Africa (Pty) Ltd, Reg. no.: 2020/176440/07. 4th Floor, Building I, Hertford Office Park, 90 Bekker Road, Midrand, 1652.
Tel: (011) 256 3700
www.sanofi.co.za